Similar articles

• Delayed maculopapular, urticarial rash due to infliximab in two children with systemic onset juvenile idiopathic arthritis.

  Tutar E, Ekici F, Naçar N, Arici S, Atalay S. Tutar E, et al. Rheumatology (Oxford). 2004 May;43(5):674-5. doi: 10.1093/rheumatology/keh142. Rheumatology (Oxford). 2004. PMID: 15103034 No abstract available.
• Crusted scabies in a patient being treated with infliximab for juvenile rheumatoid arthritis.

  Pipitone MA, Adams B, Sheth A, Graham TB. Pipitone MA, et al. J Am Acad Dermatol. 2005 Apr;52(4):719-20. doi: 10.1016/j.jaad.2004.12.039. J Am Acad Dermatol. 2005. PMID: 15793541 No abstract available.
• Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al.

  Molenaar ET, Bultink IE, Dijkmans BA, Lems WF. Molenaar ET, et al. Arthritis Rheum. 2005 Apr;52(4):1334-6. doi: 10.1002/art.20973. Arthritis Rheum. 2005. PMID: 15818690 No abstract available.
• Cryptococcal meningitis in a patient treated with infliximab.

  Muñoz P, Giannella M, Valerio M, Soria T, Díaz F, Longo JL, Bouza E. Muñoz P, et al. Diagn Microbiol Infect Dis. 2007 Apr;57(4):443-6. doi: 10.1016/j.diagmicrobio.2006.10.014. Epub 2007 Jan 19. Diagn Microbiol Infect Dis. 2007. PMID: 17240111 Review.
• Infectious complications of biologic agents.

  Martin-Mola E, Balsa A. Martin-Mola E, et al. Rheum Dis Clin North Am. 2009 Feb;35(1):183-99. doi: 10.1016/j.rdc.2009.03.009. Rheum Dis Clin North Am. 2009. PMID: 19481004 Review.